The recipients reduced and eliminated central line-associated bloodstream infections and ventilator-associated pneumonia for at least 25 months and have shared their evidence-based initiatives to help improve clinical practice, according to the release.
Click here to read the full story in Becker’s ASC Review on HAIs.
